Zhang et al. showed the LOI of IGF2 in higher frequency than other authors, 87.5% in CRC and in ~70% of control tissue, but the study was based on a relatively small number of CRC (n = 34) and control tissues (n = 14) [86]. This evidence concerns the gene IGF2 and colorectal carcinoma.